<i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> Hot-Spot Mutations in Relation to Sidedness of Primary Colorectal Cancer: A Retrospective Cohort Study
<b>Background/Objective:</b> Studies have shown an association between colorectal cancer (CRC) sidedness and gene mutations that may affect CRC clinical behavior. This study examined the association between specific <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/15/2/142 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | <b>Background/Objective:</b> Studies have shown an association between colorectal cancer (CRC) sidedness and gene mutations that may affect CRC clinical behavior. This study examined the association between specific <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> hot-spot mutations and primary CRC sidedness. <b>Methods:</b> We performed a retrospective cohort analysis of 722 patients diagnosed with primary CRC and tested for <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> hot-spot mutations at the University of Texas Medical Branch (UTMB) from January 2016 through July 2023. Multivariable logistic regressions analyses were conducted. <b>Results:</b><i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> hot-spot mutations rates were 37.8%, 4.6%, and 6.1%, respectively. Right-sided primary CRC had the highest prevalence of mutated tumors (64%). <i>KRAS</i> and <i>BRAF</i> hot-spot mutations were significantly different according to tumor sidedness. <i>KRAS</i> p.Gly12Asp, p.Gly12Val, and p.Gly13Asp showed a significantly increased likelihood of right-sided primary CRC compared to <i>KRAS</i> wildtype, 128%, 134%, and 221% higher, respectively. Conversely, <i>KRAS</i> p.Gly12Val and p.Gly13Asp mutations were associated with decreased likelihood of rectal cancer (53% lower) and left-sided tumors (56% lower), respectively. <i>BRAF</i> p.Val600Glu mutation, as opposed to <i>BRAF</i> wildtype, was associated with a 278% higher likelihood of right-sided CRC. No significant associations were observed between <i>NRAS</i> mutations and primary CRC sidedness. <b>Conclusions:</b> In primary CRC, specific mutations in <i>KRAS</i> (p.Gly12Asp, p.Gly12Val, and p.Gly13Asp) and <i>BRAF</i> p.Val600Glu were associated with increased likelihood of right-sided tumors. <i>KRAS</i> p.Gly12Val and p.Gly13Asp mutations were associated with decreased likelihood of rectal cancer and left-sided tumors, respectively. These findings suggest that tumorigenesis and mutational processes differ based on tumor sidedness. Further studies are needed to substantiate these findings. |
|---|---|
| ISSN: | 2075-4418 |